Palvella Therapeutics, Inc.

NasdaqCM:PVLA Stock Report

Market Cap: US$282.3m

Palvella Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:PVLA Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
18 Dec 24BuyUS$51,720George JenkinsIndividual4,000US$12.93

Insider Trading Volume

Insider Buying: PVLA insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of PVLA?
Owner TypeNumber of SharesOwnership Percentage
Private Companies8880.00791%
VC/PE Firms1,333,37811.9%
Hedge Funds1,411,01812.6%
Institutions1,859,70916.6%
Individual Insiders1,978,70817.6%
General Public4,637,60641.3%

Dilution of Shares: PVLA only recently listed within the past 12 months

Top Shareholders

Top 25 shareholders own 58.53% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14.3%
Wesley Kaupinen
1,607,228US$40.4m-64.2%no data
6.37%
Suvretta Capital Management, LLC
714,463US$18.0m0%0.66%
6.21%
BVF Partners L.P.
696,555US$17.5m0%0.67%
6.06%
Samsara BioCapital LLC
679,486US$17.1m33,900%3.24%
5.83%
Frazier Life Sciences Management, LP
653,892US$16.5m0%0.68%
3.73%
Cdk Associates, LLC
418,667US$10.5m0%no data
3.65%
Adams Street Partners, LLC
409,666US$10.3m0%7.41%
2.23%
Nantahala Capital Management, LLC
250,062US$6.3m0%0.45%
2.23%
CHI Advisors LLC
250,062US$6.3m0%4.02%
1.61%
George Jenkins
180,671US$4.5m88.9%no data
1.29%
ADAR1 Capital Management, LLC
144,641US$3.6m0%0.8%
1.26%
Dellora Investments LP
141,079US$3.5m0%56.63%
1%
Todd Davis
112,547US$2.8m27.7%no data
0.64%
Dafna Capital Management, LLC
71,452US$1.8m0%0.48%
0.46%
Elaine Heron
51,289US$1.3m0%no data
0.38%
BML Capital Management, LLC
42,130US$1.1m0%0.63%
0.24%
Peter P. D’Angelo
26,723US$672.4k0%no data
0.19%
Renaissance Technologies LLC
21,371US$537.7k0%no data
0.19%
Cresset Asset Management, LLC
20,911US$526.1k0%no data
0.13%
Geode Capital Management, LLC
14,270US$359.0k0%no data
0.12%
Toronto-Dominion Bank, Securities Investments
13,211US$332.4k0%no data
0.12%
BlackRock, Inc.
12,938US$325.5k0%no data
0.11%
Deltec Asset Management LLC
12,500US$314.5k0%0.06%
0.1%
The Vanguard Group, Inc.
11,342US$285.4k0%no data
0.098%
Eagles Mere Museum Foundation, Endowment Arm
11,026US$277.4k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/11 09:39
End of Day Share Price 2025/03/11 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Palvella Therapeutics, Inc. is covered by 4 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Whitney IjemCanaccord Genuity
Joshua SchimmerCantor Fitzgerald & Co.
Andrew FeinH.C. Wainwright & Co.